LIGHT CHAIN NEPHROPATHY
Clinical trials for LIGHT CHAIN NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new LIGHT CHAIN NEPHROPATHY trials appear
Sign up with your email to follow new studies for LIGHT CHAIN NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can blood filtering or a cancer drug save kidneys in myeloma patients?
Disease control CompletedThis study looks at two treatments—plasma exchange (a blood-filtering procedure) and the drug daratumumab—to see if they help patients with multiple myeloma recover from acute kidney injury caused by light chain cast nephropathy. Researchers will track 450 adults to see who survi…
Matched conditions: LIGHT CHAIN NEPHROPATHY
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New study tracks kidney health in myeloma patients on daratumumab
Knowledge-focused CompletedThis study measured certain proteins in the blood and urine of 20 newly diagnosed multiple myeloma patients before and 30 days after starting daratumumab. The goal was to see if these markers could help detect early kidney injury. Participants provided samples during routine lab …
Matched conditions: LIGHT CHAIN NEPHROPATHY
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC